Testing effectiveness (Phase 2)Study completedNCT01906489
What this trial is testing
20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Who this might be right for
AnemiaChronic Kidney Disease
Akebia Therapeutics 210